New Hope For Patients With Relapsing Multiple Sclerosis
Over two million people worldwide are estimated to suffer from multiple sclerosis (MS), which is the leading cause of neurological disability in young adults, and has a significant impact on the overall quality of life. // Currently marketed therapies afford an average reduction in relapse rates of...Researchers identify potential patient safety risks among methadone maintenance treatment patients
...ions. The BMC study appears in the July issue of Journal of General Internal Medicine . MMT is a chronic therapy for opioid dependence, a chronic relapsing disease that often requires lifelong treatment. MMT typically is provided separately from medical care. Ideally, when patients in MMT engage in outpat...New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report
...39 Vaccine II-39 Liver Transplantation II-39 Treatment Costs II-40 Types of Treatment Responses II-40 Sustained Response II-40 relapsing (Transient) Response II-40 Breakthrough Response II-40 Null Response II-40 Monitoring Tests II-41 Laboratory tests II-41 Medical E...Mayo Clinic Proceedings reviews deep brain stimulation to treat psychiatric diseases
...d 15 to 44 years, depression is the most disabling medical illness in the United States. The prevalence of major depression, known to be a chronic and relapsing illness, is approximately 17 percent, affecting almost 1 in 5 persons. Medications and psychiatric therapy can effectively treat many patients with...Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking?
... nurses and other HCPs, and 250 people living with relapsing MS. Interviews focused on understanding and compar..., MS nurses and other HCPs (n=250) and people with relapsing MS (n=250). Following their survey, physicians wer...s and problems with strength and coordination. The relapsing forms of MS are the most common. About the N...Diabetes drug shows promise against multiple sclerosis
...se in diabetes shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis, researchers at the University of Illinois at ...uroimmunology . In a small, double-blinded clinical trial, patients with relapsing remitting multiple sclerosis were assigned to take pioglitazone (a drug com...Pixantrone Now Available in Europe on a Named-Patient Basis
...he national health system. Contact Information for Program: Licensed healthcare professionals in Europe treating individual patients with relapsing or refractory aggressive non-Hodgkin's lymphoma interested in pixantrone should contact: IDIS Limited Tel: +44 (0) 1932 824 123 Fax:...Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
- Anti-IL-2 receptor antibody significantly reduced the number of new or enlarged lesions compared to placebo; data to be submitted for presentation at upcoming medical meeting - CAMBRIDGE, Mass. and FREMONT, Calif., March 12, 2007 /PRNewswire-FirstCall/ -- Biogen Idec, Inc. and PDL BioPharma, Inc...Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases
...d 15 to 44 years, depression is the most disabling medical illness in the United States. The prevalence of major depression, known to be a chronic and relapsing illness, is approximately 17 percent, affecting almost 1 in 5 persons. Medications and psychiatric therapy can effectively treat many patients wi...ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis
...Department of Neurology, Cologne City Hospitals, Germany. As previously reported, ATL/TV1102 significantly reduced disease activity in patients with relapsing Remitting Multiple Sclerosis (RRMS) in a randomized, double-blind, placebo-controlled Phase II study designed to obtain evidence of ATL/TV1102's effec...Gastroesophageal reflux disease
... Gastroesophageal Reflux Disease FAQs Introduction. Does GERD affect my heart? ... Gastroesophageal reflux disease (GERD) is a chronic, relapsing condition with ... Medical treatment of gastroesophageal reflux disease in the managed care ... The diagnosis and management of gastroe...MS study offers theory for why repair of brain's wiring fails
..., immature oligodendrocytes to the myelin sheath to repair the damage, for a time. This explains why, in the most common form of the disease, known as relapsing remitting MS, the symptoms -- which range from tingling and numbness in the limbs to loss of vision and paralysis -- disappear or are greatly reduced,...New genetic markers for ulcerative colitis identified, researchers report in Nature Genetics
... pathways involved in the disease and may lead to the development of new treatments that specifically target them. Ulcerative colitis is a chronic, relapsing disorder that causes inflammation and ulceration in the inner lining of the rectum and large intestine. The most common symptoms are diarrhea (oftenti...Positive results in Phase 2 trial of treatment of C-difficile-associated diarrhea
...nts. "We are delighted with these dramatic results. CDAD is a growing and serious epidemic, with twenty to fifty percent of hospitalized patients relapsing after receiving antibiotic treatment," said Donna Ambrosino, MD, Executive Director of the MBL and Professor of Pediatrics at UMMS. "The demonstratio...Brain-nourishing molecule may predict schizophrenia relapse
...dicates the drug is becoming less effective and a relapse is imminent, the researchers say. Decreased BDNF levels already have been associated with relapsing bipolar disease and depression, Dr. Buckley says. Dr. Pillai and others have shown that the BDNF levels in patients with schizophrenia are generally l...Cocaine: How addiction develops
...e reactivated. In contrast, NR1 deficient animals proved to be resistant to relapsing into the addiction. "It is fascinating to observe how individual prote... for treating addiction. Thus, blocking the NR1 receptor might protect from relapsing into addiction. Selective activation of GluR1 would even contribute to 'ext...Mummy lice found in Peru may give new clues about human migration
...e people who dont have the opportunity to change their clothes are the ones at risk for epidemic typhus, which along with the lesser-known diseases of relapsing fever and trench fever are carried by body lice, Reed said. These pests lay their eggs in clothing fibers and washing the clothes is all it takes to g...Staphylococcus aureus hides out in cells
...considered an intracellular pathogen, but the molecular details that govern its extended persistence remain largely unknown. The bacteria can generate relapsing infections even years after the first episode was apparently cured. “S. aureus intracellular survival appears related to its capability to adopt ...Susceptibility to Crohn's disease -- an important new clue
... Crohn’s disease is a chronic relapsing inflammatory disorder of the intestinal tract that affects an estimated 0.15% of people in the developed world. Common symptoms include abdominal pain...Novel mechanism of action of new drug for MS identified
... a drug developed by Novartis, has shown considerable therapeutic effects in a recent small, placebo-controlled clinical trial involving patients with relapsing multiple sclerosis. The study was published in the September 2006 issue of the New England Journal of Medicine by an international research team. With...Altered perception of reward in human cocaine addiction
...s. "The dysfunctional interplay between reward processing and control of behavior observed in these studies could help to explain the chronically relapsing nature of drug addiction," Goldstein said. "Our results also suggest the need for new clinical interventions aimed at helping drug abusers manage thes...Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
...disease. Prior to that, Lorianne held senior leadership positions at Chiron and Berlex, where she was instrumental in development of Betaseron(R) for relapsing forms of multiple sclerosis as well as numerous oncology programs. Dr. Masuoka received her M.D. from the University of California, Davis , co...AEterna Zentaris Presents Data Supporting Evaluation of AEZS-108 in Prostate Cancer at ASCO Meeting
... Conclusion - In virtually all patients with prostate cancer, tumor cells appear to express LHRH receptors; - Even tumors persisting or relapsing after castration or prolonged hormonal treatment with LHRH agonists retain the expression of LHRH receptors; - The continued expressio...BioMS Medical recognized at Scrip Awards 2008
...als for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. For further information please visit our website at http://biomsmedical.com ...Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at ASH
...b is being developed to treat chronic lymphocytic leukemia, follicular non-Hodgkin's lymphoma, diffuse large B-cell lymphoma, rheumatoid arthritis and relapsing remitting multiple sclerosis under a co-development and commercialization agreement between Genmab and GlaxoSmithKline. It is not yet approved for sal...Peptimmune Presentations at Upcoming Events
...ing establishment of safety at potentially therapeutic doses and proof of pharmacologic mechanism, the Company plans to initiate its Phase II study in relapsing remitting multiple sclerosis patients in early 2009. PI-2301 is a second-generation peptide copolymer from a similar compound class as Copaxone(R) (...Genmab Reaches Milestone in Ofatumumab Collaboration
...b is being developed to treat chronic lymphocytic leukemia, follicular non-Hodgkin's lymphoma, diffuse large B-cell lymphoma, rheumatoid arthritis and relapsing remitting multiple sclerosis under a co- development and commercialization agreement between Genmab and GlaxoSmithKline. It is not yet approved for sa...Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis
...ing establishment of safety at potentially therapeutic doses and proof of pharmacologic mechanism, the Company plans to initiate its Phase II study in relapsing remitting multiple sclerosis patients in early 2009. PI-2301 is a second-generation peptide copolymer from a similar compound class as Copaxone(R) (...JADO Reports Clinical Proof of Concept With Raft Modulator in Atopic Dermatitis
...itis is the most common form of the inflammatory skin disorder, eczema. Approximately 10-20% of the world's population is affected by this chronic and relapsing condition which has a severe impact on quality of life. In many, the condition manifests during childhood, however more than 50% continues to experien...